Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000226089 designates a **novel, uncharacterized long noncoding RNA transcript** that is located on chromosome 6, on the reverse strand, within an intronic region of the FAM46A (also known as TENT5A) gene[2][3]. No protein product is annotated for this transcript, and its biological function, molecular mechanism, or contribution to disease is not established in available gene function databases or the biomedical literature as of the current date[1][2][3]. There are no aliases, interacting drugs, or established roles as a biomarker or therapeutic target. This entry appears to exist only as a transcript annotation by large genome databases and lacks experimental characterization.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to FAM46A (ENSG00000226089).